Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial

NCT04259944 is registered in ClinicalTrials.gov with IFOM ETS - The AIRC Institute of Molecular Oncology as lead sponsor.

NCT NCT04259944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04259944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial
Lead sponsor
IFOM ETS - The AIRC Institute of Molecular Oncology
Phase
Phase 2
Overall status
Unknown status
Start date
June 16, 2020
Completion date
October 15, 2024
Enrollment
140 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer